ArticleJournal of medical virology2022

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.

Thomas Theo Brehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.